期刊文献+

脂联素在类风湿关节炎患者血清中的变化及其临床意义 被引量:4

The role and significance of adiponectin in the pathogenesis of rheumatoid arthritis
原文传递
导出
摘要 目的测定RA患者血清中脂联素水平,探讨脂联素在RA患者中的临床意义。方法用ELISA法检测53例RA及31名健康对照组血清脂联素水平,分析脂联素与临床及实验室指标的相关性。统计学方法采用t检验、单因素方差分析和Spearman相关分析。结果RA组血清脂联素水平明显高于健康对照组[(12±8)txg/ml和(8±4)04/ml,t=3.694,P=0.0023。RA组脂联素与RF、抗CCP抗体滴度呈负相关(r=-0.301,r=-0.290,P均<0.05),与球蛋白、IgA、IgM呈正相关(r=0.492,r=0.431,r=0.485,P均<0.05),与ESR、CRP、DAS28、体质量指数(BMI)、抗链球菌溶血素(ASO)、IgG、肝肾功能、Tc、TG、补体、凝血酶原时间(PT)系列等无相关性(JP均>O.05)。病程10~15年的RA患者脂联素与BMI呈负相关(r=-0.197,P<0.05)。结论脂联素可能与RA的自身抗体产生有关,参与RA炎性活动过程。 Objective To study the expression of adiponeetin in the peripheral blood of patients with rheumatoid arthritis (RA), and discuss its role in the pathogenesis of RA. Methods Fifty-three patients with RA and 31 healthy controls were enrolled in the study. The level of adiponectin in the peripheral blood were detected using enzyme-linked immunosorbent assay (ELISA) method and the relation with clinical and laboratory parameters were analyzed. The stastistical analysis was carried out with independent t-test, one-way ANOVA and Spearman correlation analysis. Results The level of the adiponectin in rheumatoid arthritis patients [ ( 12±8 ) μg/ml ] was higher than control group [ (8±4)μg/ml], with statistically significant difference (t=3.694, P=O.002). The level of adiponectin of the experimental group was negatively correlated with rheumatoid factor (RF), anti-cyclic centrullinated peptides (anti-CCP) (r=-0.301, r=-0.290, P〈O.05 ) and positively correlated with the levels of globulin (GLO), IgA and IgM (r=0.492, r=0.431, r=0.485, P〈O.05), while no significant correlation (P〉0.05) with erythrocyte sedimentation rate (ESR), C reactive protein (CRP), disease activity score in 28 joints (DAS28), Body mass index (BMI), anti streptolysin O (ASO), IgG, liver and kidney function, triglyceride (TG) and cholesterol (TC), C3, C4 levels and prothrombin time (PT) series. The level of adiponectin of the whole experimental group was not significantly correlated with BMI (r=0.142, P〉0.05), but negatively correlated with BMI (r=0.197, P〈0.05) in patients with 10-15 years courses of disease. Conclusion Related to RF and CCP, adiponeetin may be involved in the pathogenesis of chronic inflammation of RA.
出处 《中华风湿病学杂志》 CAS CSCD 北大核心 2014年第8期549-551,共3页 Chinese Journal of Rheumatology
关键词 关节炎 类风湿 自身抗体 脂联素 Arthritis, rheumatoid Autoantibodies Adiponectin
  • 相关文献

参考文献15

  • 1Chen X, Lu J, Bao J, et al. Adiponectin: a biomarker for rheumatoid arthritis [J]. Cytokine Growth Factor Rev, 2013, 24: 83-89.
  • 2Alkady EA, Ahmed HM, Tag L, et al. Serum and synovial adiponectin, resistin, and visfatin levels in rheumatoid arthritis patients: relation to disease activity[J]. Z Rheumatol, 2011, 70: 602-608.
  • 3Yoshino T, Kusunoki N, Tanaka N, et al. Elevated serum levels of resistin, leptin dnd adiponectin are associated with C-reactive protein and also other clinical conditions in rheumatoid arthritis [J]. Intern Med, 2011, 50: 269-275.
  • 4Preslele N, Pottie P, Dumond H, et al. Differential distribution of adipokines between serum and synovial fluid in patients with osteoarthritis: contribution of joint tissues to their articular pro- duction[J]. Osteoarthritis Cartilage, 2006, 14: 690-695.
  • 5刘婷,谈文峰,张缪佳.类风湿关节炎患者血清脂联素水平的变化及意义[J].江苏医药,2010,36(15):1744-1746. 被引量:5
  • 6Targoitska-St:pniak B, Dryglewska M, Majdan M. Adiponectin and leptin serum concentrations in patients with rheumatoid arthrltis[J]. Rheumatol Int, 2010, 30: 731-737.
  • 7Cansu B, Cansu DU, Ka:ifo:lu T, et al. Disease-modifying an- tirheumatic drugs increase serum adiponectin levels in patients with rheumatoid arthritis[J]. J Clin Rheumatol, 2011, 17: 14-17.
  • 8王芳,谈文峰,张缪佳,郭敦明,刘晓华,沈友轩,柯瑶,何韶衡.脂肪因子脂联素及其受体在类风湿关节炎炎性关节中高表达[J].中华风湿病学杂志,2009,13(11):745-748. 被引量:8
  • 9Senolt L, Pavelka K, Housa D, et al. Increased adiponectin is negatively linked to the local inflammatory process in patients with rheumatoid arthritis[J]. Cytokine, 2006, 35: 247-252.
  • 10Kitabara K, Kusunoki N, Kakiuchi T, et al. Adiponectin stimu- lates IL-8 production by rheumatoid synovial fibroblasts [J]. Biochem Biophys Res Commun, 2009, 378: 218-223.

二级参考文献32

  • 1谈文峰,王芳,张缪佳,刘晓华,郭敦明,朱晓敏,张海地.运用基因芯片初步研究类风湿关节炎患者外周血单个核细胞基因表达谱特征[J].中华风湿病学杂志,2006,10(12):745-750. 被引量:6
  • 2Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab, 2004. 89: 2548-2556.
  • 3Coppaek S. Pro-inflammatory cytokines and adipose tissue. Proc Nutr Soc, 2001, 60: 349-356.
  • 4Chaldakov GN, Stankulov IS, Hristova M, et al. Adipobiology of disease: adipokines and adipocytokine-targeted pharmacology. Curr Pharm Des, 2003, 9: 1023-t031.
  • 5Schaffler A, Ehling A, Neumann E, et al. Adipocytokines in synovial fluid. J Am Med. Assoc, 2003, 290: 1709-1710.
  • 6Yamauchi T, Kamon J, lto Y, et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature, 2003, 423: 762-769.
  • 7Distmar K, Barbara S, Gertraud H, et al. Response to mcthotrexate treatment is associated with reduced mortality in patients with severe rheumatoid arthritis. Arthritis Rheum, 2000, 43: 14-21.
  • 8Giamila F. Adipose tissue, adipokines, and inflammation. J Allergy Clin lmmunol, 2005, 115:911-919.
  • 9Tomasz M, Zhang L, Andrew Z, et al. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation, 2003, 108: 2460-2466.
  • 10Karmiris K, Koutroubakis IE, Kouroumalis EA. The emerging role of adipocytokines as inflammatory mediators in inflammatory bowel disease, hfflamm Bowel Dis, 2005, 11: 847-855.

共引文献10

同被引文献33

  • 1Sen D,González-Mayda M,Brasington RD Jr.Cardiovascular disease in rheumatoid arthritis.Rheum Dis Clin North Am,2014,40:27-49.
  • 2Adya R,Tan BK,Randeva HS.Differential effects of leptin and adiponectin in endothelial angiogenesis.J Diabetes Res,2015,2015:648239.
  • 3Dessein PH,Tsang L,Solomon A,et al.Adiponectin and atherosclerosis in rheumatoid arthritis.Mediators Inflamm,2014,2014:358949.
  • 4El-Hini SH,Mohamed FI,Hassan AA,et al.Visfatin and adiponectin as novel markers for evaluation of metabolic disturbance in recently diagnosed rheumatoid arthritis patients.Rheumatol Int,2013,33:2283-2289.
  • 5Arnett FC,Edworthy SM,Bloch DA,et al.The American Rheumatism Association 1987revised criteria for the classification of rheumatoid arthritis.Arthritis Rheum,1988,31:315-324.
  • 6Liao KP,Solomon DH.Traditional cardiovascular risk factors,inflammation and cardiovascular risk in rheumatoid arthritis.Rheumatology(Oxford),2013,52:45-52.
  • 7Oranskiy SP,Yeliseyeva LN,Tsanaeva AV,et al.Body composition and serum levels of adiponectin,vascular endothelial growth factor,and interleukin-6in patients with rheumatoid arthritis.Croat Med J,2012,53:350-356.
  • 8Ohashi K,Parker JL,Ouchi N,et al.Adiponectin promotes macrophage polarization toward an anti-inflammatory phenotype.J Biol Chem,2010,285:6153-6160.
  • 9Yoshino T,Kusunoki N,Tanaka N,et al.Elevated serum levels of resistin,leptin,and adiponectin are associated with C-reactive protein and also other clinical conditions in rheumatoid arthritis.Intern Med,2011,50:269-275.
  • 10Shibata R,Murohara T,Ouchi N.Protective role of adiponectin in cardiovascular disease.Curr Med Chem,2012,19:5459-5466.

引证文献4

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部